Biaxin XL Gets 40% Of New Clarithromycin Scripts In December, Abbott Says
Executive Summary
Abbott's once-daily Biaxin XL is cannibalizing close to half of the company's clarithromycin franchise, the company told investors during a Jan. 16 fourth quarter earnings call.